Future Biomarkers for Infection and Inflammation in Rheumatoid Arthritis

Shuang Cui1, Jie Qian1

  • 1Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, 226001, People's Republic of China.

Insights

Diagnosing infections in rheumatoid arthritis (RA) patients is challenging due to atypical symptoms. Novel biomarkers like presepsin and immune cell analysis offer improved accuracy in distinguishing infection from inflammation, guiding treatment decisions.

Area of Science:

  • Immunology
  • Rheumatology
  • Infectious Diseases

Background:

  • Rheumatoid arthritis (RA) compromises immune function, increasing infection susceptibility.
  • Differentiating infection from aseptic inflammation in RA patients is clinically challenging.
  • Current diagnostic markers lack specificity for bacterial infections in immunosuppressed individuals.

Purpose of the Study:

  • To review novel biomarkers for identifying infections in rheumatoid arthritis (RA) patients.
  • To discuss biomarkers capable of distinguishing infection from inflammation.
  • To highlight potential biomarkers for improved clinical decision-making in RA management.

Main Methods:

  • Literature review of novel biomarkers in RA patients with infection.
  • Analysis of biomarkers including presepsin, serology, haematology, neutrophils, T cells, and natural killer cells.
  • Discussion of biomarkers differentiating infection from inflammation.

Main Results:

  • Several novel biomarkers, including presepsin and immune cell profiles, show promise in identifying infections in RA.
  • These biomarkers offer potential to differentiate between infection and aseptic inflammation.
  • Current traditional markers are insufficient for accurate diagnosis in this population.

Conclusions:

  • Novel biomarkers are crucial for accurate and timely diagnosis of infections in RA patients.
  • Effective differentiation between infection and inflammation aids in appropriate treatment strategies.
  • Further development and validation of these biomarkers will enhance clinical practice for RA management.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
123
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
175